Zymeworks, Inc. (ZYME)
25.72
-0.08
(-0.33%)
USD |
NASDAQ |
Dec 10, 13:50
Zymeworks Shareholders Equity (Quarterly): 320.06M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 3.959B |
| Johnson & Johnson | 79.28B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Vertex Pharmaceuticals, Inc. | 17.32B |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 397.27M |
| Total Liabilities (Quarterly) | 77.20M |
| Debt to Equity Ratio | 0.0591 |
| Current Ratio | 6.938 |
| Net Debt Paydown Yield | 0.02% |